These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 9863863)

  • 1. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy.
    Kroon FP; Rimmelzwaan GF; Roos MT; Osterhaus AD; Hamann D; Miedema F; van Dissel JT
    AIDS; 1998 Dec; 12(17):F217-23. PubMed ID: 9863863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
    Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes.
    Kroon FP; van Dissel JT; de Jong JC; van Furth R
    AIDS; 1994 Apr; 8(4):469-76. PubMed ID: 7912086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Powell AM; Luo Z; Martin L; Wan Z; Ma L; Liao G; Song Y; Li X; Michael Kilby J; Huang L; Jiang W
    Vaccine; 2017 Feb; 35(5):831-841. PubMed ID: 28017428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients.
    Cagigi A; Pensieroso S; Ruffin N; Sammicheli S; Thorstensson R; Pan-Hammarström Q; Hejdeman B; Nilsson A; Chiodi F
    Vaccine; 2013 Apr; 31(18):2231-7. PubMed ID: 23499520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy.
    Viganò A; Zuccotti GV; Pacei M; Erba P; Castelletti E; Giacomet V; Amendola A; Pariani E; Tanzi E; Clerici M
    J Acquir Immune Defic Syndr; 2008 Jul; 48(3):289-96. PubMed ID: 18545155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.
    Rinaldi S; Zangari P; Cotugno N; Manno EC; Brolatti N; Castrucci MR; Donatelli I; Rossi P; Palma P; Cagigi A
    Vaccine; 2014 Feb; 32(6):657-63. PubMed ID: 24333344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients.
    Fowke KR; D'Amico R; Chernoff DN; Pottage JC; Benson CA; Sha BE; Kessler HA; Landay AL; Shearer GM
    AIDS; 1997 Jul; 11(8):1013-21. PubMed ID: 9223736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation.
    Parmigiani A; Alcaide ML; Freguja R; Pallikkuth S; Frasca D; Fischl MA; Pahwa S
    PLoS One; 2013; 8(11):e79816. PubMed ID: 24236161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard-Dose Intradermal Influenza Vaccine Elicits Cellular Immune Responses Similar to Those of Intramuscular Vaccine in Men With and Those Without HIV Infection.
    Amoah S; Mishina M; Praphasiri P; Cao W; Kim JH; Liepkalns JS; Guo Z; Carney PJ; Chang JC; Fernandez S; Garg S; Beacham L; Holtz TH; Curlin ME; Dawood F; Olsen SJ; Gangappa S; Stevens J; Sambhara S
    J Infect Dis; 2019 Jul; 220(5):743-751. PubMed ID: 31045222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.
    Agrati C; Gioia C; Castilletti C; Lapa D; Berno G; Puro V; Carletti F; Cimini E; Nisii C; Castellino F; Martini F; Capobianchi MR
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1606-16. PubMed ID: 22439734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy.
    Tanzi E; Esposito S; Bojanin J; Amendola A; Trabattoni D; Pariani E; Pinzani R; Zanetti A; Principi N
    J Med Virol; 2006 Apr; 78(4):440-5. PubMed ID: 16482542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study.
    Kroon FP; van Dissel JT; de Jong JC; Zwinderman K; van Furth R
    Vaccine; 2000 Jul; 18(26):3040-9. PubMed ID: 10825608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy.
    Iorio AM; Francisci D; Camilloni B; Stagni G; De Martino M; Toneatto D; Bugarini R; Neri M; Podda A
    Vaccine; 2003 Sep; 21(25-26):3629-37. PubMed ID: 12922092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.
    Luo Z; Ma L; Zhang L; Martin L; Wan Z; Warth S; Kilby A; Gao Y; Bhargava P; Li Z; Wu H; Meissner EG; Li Z; Kilby JM; Liao G; Jiang W
    Vaccine; 2016 Apr; 34(16):1945-55. PubMed ID: 26721328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
    Günthard HF; Wong JK; Spina CA; Ignacio C; Kwok S; Christopherson C; Hwang J; Haubrich R; Havlir D; Richman DD
    J Infect Dis; 2000 Feb; 181(2):522-31. PubMed ID: 10669335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients.
    Yamanaka H; Teruya K; Tanaka M; Kikuchi Y; Takahashi T; Kimura S; Oka S;
    J Acquir Immune Defic Syndr; 2005 Jun; 39(2):167-73. PubMed ID: 15905732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection.
    Lange CG; Lederman MM; Medvik K; Asaad R; Wild M; Kalayjian R; Valdez H
    AIDS; 2003 Sep; 17(14):2015-23. PubMed ID: 14502004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up.
    Hejdeman B; Leandersson AC; Fredriksson EL; Sandström E; Wahren B; Bratt G
    HIV Med; 2003 Apr; 4(2):101-10. PubMed ID: 12702130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.